Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

OGEN holding history

Oragenics Inc in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OGEN overviewAll 13F holders of OGENFull Q4 2025 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q1 2021
Holdings of OGEN by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−84,386−100.0%Sold outConverted for a 1-for-60 splitHolders
Q4 20225,063,135$532.1K<0.1%+2,0120.0%AddedHolders
Q3 20225,061,123$1.15M<0.1%00.0%UnchangedHolders
Q2 20225,061,123$1.75M<0.1%00.0%UnchangedHolders
Q1 20225,061,123$1.74M<0.1%−24,038−0.5%ReducedHolders
Q4 20215,085,161$2.27M<0.1%+32,793+0.6%AddedHolders
Q3 20215,052,368$3.21M<0.1%+20,918+0.4%AddedHolders
Q2 20215,031,450$3.55M<0.1%+512,013+11.3%AddedHolders
Q1 20214,519,437$4.10M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.